Cancer Research Meeting Calendar  Protein Translation and Cancer
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

[Cancer Research 11, 801-806, October 1, 1951]
© 1951 American Association for Cancer Research

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Finkelstein, M.
Right arrow Articles by Thomas, P. A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Finkelstein, M.
Right arrow Articles by Thomas, P. A.

Studies on the Effect of 8-Azaguanine on Sarcoma 37 in Mice* ,{dagger}

Murray Finkelstein and Paul A. Thomas

( Department of Pharmacology, the George Washington University School of Medicine, Washington, D.C.)

1. Data are presented on the effect of single and multiple doses of 8-azaguanine on growth, morphology, and drug toxicity in normal and tumorbearing mice.
2. Multiple doses of 8-azaguanine produced a definite inhibition of growth and extreme cellular damage of Sarcoma 37.
3. Gross tumor damage was observed within 2–6 hours, with extensive morphological damage 24 hours after a single large dose of 8-azaguanine.
4. The number of mitotic figures in tumors after repeated doses of 8-azaguanine approached that of control tumors, whereas after a single large dose it was approximately one-fifth that seen in controls.
5. The drug was not completely destructive to this tumor. Progressively less effect on growth and morphology was seen on cessation of therapy.
6. No well defined separation of the tumor-inhibitory action of 8-azaguanine from systemic and morphological effects of the drug was apparent. The toxic action was similar in normal and tumorbearing mice. Multiple doses produced morphological spleen and adrenal damage.

* This investigation was supported by a research grant from the National Cancer Institute, National Institutes of Health, Public Health Service.

{dagger} The authors are indebted to Dr. H. George Mandel for the supply of 8-azaguanine and to the National Cancer Institute for the initial tumors and the mice employed in this investigation.

Received 6/30/51.





HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 1951 by the American Association for Cancer Research.